M&T Bank Corp Zimmer Biomet Holdings, Inc. Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 26,719 shares of ZBH stock, worth $2.87 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,719

Previous 26,719 -0.0%

Holding current value

$2.87 Million

Previous $2.88 Million -0.0%

% of portfolio

0.01%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$104.47 - $116.17 $909,829 - $1.01 Million	8,709 Added 48.36%	26,719 $2.88 Million
Q2 2024 Jul 31, 2024	SELL	$106.25 - $130.01 $31,343 - $38,352	-295 Reduced 1.61%	18,010 $1.95 Million
Q1 2024 May 07, 2024	SELL	$119.98 - $132.61 $59,030 - $65,244	-492 Reduced 2.62%	18,305 $2.42 Million
Q4 2023 Feb 06, 2024	SELL	$102.72 - $121.7 $73,855 - $87,502	-719 Reduced 3.68%	18,797 $2.29 Million
Q3 2023 Nov 02, 2023	SELL	$110.76 - $143.18 $554,132 - $716,329	-5,003 Reduced 20.4%	19,516 $2.19 Million
Q2 2023 Aug 09, 2023	SELL	$126.43 - $145.6 $290,662 - $334,734	-2,299 Reduced 8.57%	24,519 $3.57 Million
Q1 2023 May 11, 2023	BUY	$121.91 - $130.94 $105,208 - $113,001	863 Added 3.32%	26,818 $3.46 Million
Q4 2022 Feb 13, 2023	SELL	$104.7 - $128.4 $250,023 - $306,619	-2,388 Reduced 8.4%	26,053 $3.32 Million
Q4 2022 Feb 13, 2023	SELL	$104.7 - $128.4 $10,260 - $12,583	-98 Reduced 0.38%	25,955 $3.31 Million
Q3 2022 Nov 14, 2022	SELL	$101.65 - $119.27 $124,419 - $145,986	-1,224 Reduced 4.13%	28,441 $2.9 Million
Q2 2022 Aug 05, 2022	BUY	$102.23 - $133.85 $758,035 - $992,497	7,415 Added 33.33%	29,665 $2.37 Million
Q1 2022 May 09, 2022	SELL	$108.42 - $129.58 $322,766 - $385,759	-2,977 Reduced 11.8%	22,250 $2.85 Million
Q4 2021 Feb 07, 2022	SELL	$115.43 - $146.63 $1.25 Million - $1.58 Million	-10,798 Reduced 29.97%	25,227 $3.21 Million
Q3 2021 Oct 28, 2021	BUY	$136.35 - $158.76 $35,451 - $41,277	260 Added 0.73%	36,025 $5.27 Million
Q2 2021 Aug 13, 2021	BUY	$152.95 - $173.41 $167,480 - $189,883	1,095 Added 3.16%	35,765 $5.75 Million
Q1 2021 May 06, 2021	BUY	$148.16 - $159.71 $631,013 - $680,204	4,259 Added 14.0%	34,670 $5.55 Million
Q4 2020 Feb 12, 2021	BUY	$128.25 - $151.41 $131,841 - $155,649	1,028 Added 3.5%	30,411 $4.69 Million
Q3 2020 Nov 06, 2020	BUY	$113.59 - $141.68 $45,776 - $57,097	403 Added 1.39%	29,383 $4 Million
Q2 2020 Jul 29, 2020	SELL	$87.02 - $133.4 $262,017 - $401,667	-3,011 Reduced 9.41%	28,980 $3.46 Million
Q1 2020 May 14, 2020	SELL	$78.28 - $155.73 $170,024 - $338,245	-2,172 Reduced 6.36%	31,991 $3.23 Million
Q4 2019 Feb 07, 2020	BUY	$127.4 - $146.83 $47,010 - $54,180	369 Added 1.09%	34,163 $5.11 Million
Q3 2019 Nov 12, 2019	SELL	$113.33 - $138.46 $33,772 - $41,261	-298 Reduced 0.87%	33,794 $4.64 Million
Q2 2019 Aug 12, 2019	SELL	$108.87 - $125.09 $88,837 - $102,073	-816 Reduced 2.34%	34,092 $4.01 Million
Q1 2019 May 15, 2019	BUY	$97.5 - $125.79 $182,032 - $234,849	1,867 Added 5.65%	34,908 $4.46 Million
Q4 2018 Feb 01, 2019	SELL	$94.4 - $126.76 $1.24 Million - $1.66 Million	-13,127 Reduced 28.43%	33,041 $3.43 Million
Q3 2018 Nov 09, 2018	BUY	$108.41 - $127.64 $44,014 - $51,821	406 Added 0.89%	46,168 $6.07 Million
Q2 2018 Aug 10, 2018	SELL	$102.12 - $114.04 $21,853 - $24,404	-214 Reduced 0.47%	45,762 $5.1 Million
Q1 2018 May 04, 2018	SELL	$104.31 - $124.46 $26,181 - $31,239	-251 Reduced 0.54%	45,976 $5.01 Million
Q4 2017 Feb 06, 2018	SELL	$105.55 - $120.83 $551,604 - $631,457	-5,226 Reduced 10.16%	46,227 $5.58 Million
Q3 2017 Nov 13, 2017	SELL	$106.92 - $117.79 $378,603 - $417,094	-3,541 Reduced 6.44%	51,453 $6.02 Million
Q2 2017 Aug 11, 2017	BUY	N/A	54,994	54,994 $7.06 Million

Others Institutions Holding ZBH

# of Institutions

1,079

Shares Held

178M

Call Options Held

301K

Put Options Held

View Full List

About ZIMMER BIOMET HOLDINGS, INC.

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $22.5B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

More about ZBH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account